Hypertension Diagnostics Company Top Insiders

HDII Stock  USD 0.0001  0.00  0.00%   
Hypertension Diagnostics employs about 5 people. The company is managed by 3 executives with a total tenure of roughly 12 years, averaging almost 4.0 years of service per executive, having 1.67 employees per reported executive. Assessment of Hypertension Diagnostics' management performance can provide insight into the firm performance.
Joseph DAlbero  Insider
Exec
Liangjian Peng  Insider
Chief Officer
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hypertension Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Hypertension Diagnostics Management Team Effectiveness

Hypertension Diagnostics' management efficiency ratios could be used to measure how well Hypertension Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities.
Some institutional investors establish a significant position in pink sheets such as Hypertension Diagnostics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Hypertension Diagnostics, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Hypertension Diagnostics Workforce Comparison

Hypertension Diagnostics is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 58.0. Hypertension Diagnostics holds roughly 5.0 in number of employees claiming about 9% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average.

Hypertension Diagnostics Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Hypertension Diagnostics Price Series Summation is a cross summation of Hypertension Diagnostics price series and its benchmark/peer.

Hypertension Diagnostics Notable Stakeholders

A Hypertension Diagnostics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Hypertension Diagnostics often face trade-offs trying to please all of them. Hypertension Diagnostics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Hypertension Diagnostics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
String symbol = request.getParameter("s");

About Hypertension Diagnostics Management Performance

The success or failure of an entity such as Hypertension Diagnostics often depends on how effective the management is. Hypertension Diagnostics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Hypertension management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Hypertension management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada. Hypertension Diag operates under Shell Companies classification in the United States and is traded on OTC Exchange.

Hypertension Diagnostics Workforce Analysis

Traditionally, organizations such as Hypertension Diagnostics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Hypertension Diagnostics within its industry.

Hypertension Diagnostics Manpower Efficiency

Return on Hypertension Diagnostics Manpower

Revenue Per Employee758.4K
Revenue Per Executive1.3M
Net Loss Per Employee25.1K
Net Loss Per Executive41.8K

Complementary Tools for Hypertension Pink Sheet analysis

When running Hypertension Diagnostics' price analysis, check to measure Hypertension Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hypertension Diagnostics is operating at the current time. Most of Hypertension Diagnostics' value examination focuses on studying past and present price action to predict the probability of Hypertension Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hypertension Diagnostics' price. Additionally, you may evaluate how the addition of Hypertension Diagnostics to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios